Head of the Congenital Heart Disease Subspecialty Group, Chief Physician, Doctoral Supervisor
Affiliated HospitalWest China Hospital of Sichuan University
→
Research areas : interventional treatment of structural heart disease; congenital heart disease; pulmonary vascular intervention.
Cutting-edge technology: In 2014, a joint hybrid cardiac surgery was performed on a 9-day-old infant with congenital heart disease; in 2019, the first aortic coarctation stent implantation was performed on a critically ill newborn in China; a participant in the world's first human trial of aortic valve "stem valve" implantation; and conducted international teaching on transcatheter pulmonary valve replacement in Turkey.
Specializes in treating: congenital heart disease, pulmonary vascular disease, and structural heart disease.
Academic Highlights: Member of the Structural Heart Disease Group and Pulmonary Vascular Disease Group of the Cardiovascular Disease Branch of the Chinese Medical Association; Third Prize of Huaxia Medical Science and Technology Award (2018); Promoted the international application of the Chinese-made medical device VenusP-Valve.